# Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy

> **NCT04826328** · PHASE1 · COMPLETED · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 85 (actual)

## Conditions studied

- Pain, Postoperative
- Bunion

## Interventions

- **DRUG:** FX301
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT04826328
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-15
- **Primary completion:** 2022-01-11
- **Final completion:** 2022-03-30
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2022-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826328, "Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04826328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*